{"nct_id":"NCT04003623","title":"Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)","status":"TERMINATED","status_verified_date":"2022-04","start_date":"2019-10-31","start_date_type":"ACTUAL","primary_completion_date":"2020-06-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}